( NYSE:AGN )

News from Allergan plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jun 14, 2018, 08:00 ET Allergan Continues Active Board Refreshment Process

Allergan plc (NYSE: AGN) today announced that Thomas C. Freyman will join its Board of Directors effective immediately, as part of the company's...


Jun 13, 2018, 08:00 ET Allergan Announces Positive Topline Phase 3 Clinical Data for Bimatoprost SR (Sustained-Release) Implant for IOP Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension

Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, today announced the release of new topline clinical trial data on Bimatoprost...


Jun 11, 2018, 08:00 ET Allergan's Oral CGRP Receptor Antagonist Atogepant Demonstrates Robust Efficacy and Safety in Episodic Migraine Prevention in a Phase 2b/3 Clinical Trial

Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, today announced positive results from CGP-MD-01, a Phase 2b/3 clinical trial...


Jun 07, 2018, 08:30 ET Allergan and Actress Shay Mitchell Join Forces to Inspire Women to Know Their Birth Control

Allergan plc (NYSE: AGN), a leader in women's healthcare and the maker of Lo Loestrin® Fe (norethindrone acetate and ethinyl estradiol tablets,...


Jun 05, 2018, 13:42 ET Allergan Responds to Public Shareholder Letter

Allergan plc (NYSE: AGN) today issued the following statement in response to a public shareholder letter: Allergan's board of directors and...


Jun 05, 2018, 08:00 ET Allergan Teams Up with a Host of Celebrities to Encourage Alzheimer's Patients and their Caregivers to Hold on to Hope

Allergan plc (NYSE:AGN) today announced that, in honor of Alzheimer's & Brain Awareness Month, it is teaming up with notable celebrities Scott...


May 29, 2018, 08:57 ET Allergan Issues Nationwide Voluntary Recall of TAYTULLA® Softgel Capsules 1mg/20mcg Sample Packs Due to Out of Sequence Capsules

Allergan plc (NYSE:AGN) today issued a voluntary recall in the US market of one lot (Lot# 5620706, Expiry May-2019) of TAYTULLA® (norethindrone...


May 16, 2018, 16:15 ET Allergan to Present at the Bernstein Strategic Decisions Conference

Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will present at the...


May 07, 2018, 16:15 ET Allergan to Present at the Bank of America Merrill Lynch Healthcare Conference

Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chief Commercial Officer William Meury will present at...


May 03, 2018, 17:00 ET John Davidson Elected to Allergan Board of Directors

Allergan plc (NYSE: AGN) today announced that John Davidson has been elected to its Board of Directors. Mr. Davidson and the other directors...


May 03, 2018, 16:30 ET Allergan Declares Second Quarter 2018 Cash Dividend of $0.72 Per Ordinary Share

Allergan plc (NYSE: AGN) today announced that its Board of Directors has declared a cash dividend of $0.72 per ordinary share for the second...


May 02, 2018, 08:00 ET Allergan to Present Data from a Robust Mental Health Clinical Program at the American Psychiatric Association (APA) 2018 Annual Meeting

Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that they will showcase new data during the upcoming American...


May 01, 2018, 16:15 ET Allergan to Present at the Deutsche Bank 43rd Annual Health Care Conference

Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chief Financial Officer Matthew Walsh will present at...


May 01, 2018, 16:01 ET Allergan and Ironwood Launch Interactive Digital Destination During Irritable Bowel Syndrome (IBS) Awareness Month Designed to Encourage Sufferers to Get Educated and Take Action

Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a commercial biotech company,...


Apr 30, 2018, 07:00 ET Allergan Reports 3% Increase in First Quarter 2018 GAAP Net Revenues to $3.7 Billion

Allergan plc (NYSE: AGN) today reported its first quarter 2018 continuing operations performance. Total first quarter 2018 net revenues were $3.67...


Apr 27, 2018, 08:00 ET Allergan Announces Second Positive Phase 3 Clinical Trial for Ubrogepant -- an Oral CGRP Receptor Antagonist for the Acute Treatment of Migraine

Allergan plc, (NYSE: AGN), a leading global pharmaceutical company today announced positive results from ACHIEVE II (UBR-MD-02), the second of two...


Apr 26, 2018, 17:01 ET Allergan to Present New Data at the American College of Obstetrics and Gynecology 67th Annual Clinical and Scientific Meeting 2018

Allergan plc, (NYSE: AGN) a leading global pharmaceutical company, will present new data at the annual Clinical and Scientific Meeting of the...


Apr 26, 2018, 08:01 ET Allergan Presents Data at the Annual Meeting of the Association of Research in Vision and Ophthalmology (ARVO) Annual Meeting in Honolulu

Allergan plc (NYSE: AGN) today announced that 19 Allergan-supported abstracts were selected for poster presentations at the Annual Meeting of the...


Apr 20, 2018, 08:01 ET Allergan Showcases Leadership in Neurosciences with 25 Presentations at the American Academy of Neurology Annual Meeting in Los Angeles

Allergan plc (NYSE: AGN), a leading global pharmaceutical company announced today that the company will share 25 presentations at the 70th Annual...


Apr 19, 2018, 14:19 ET Allergan Does Not Intend to Make an Offer for Shire plc; Strategic Review Continues

In order to comply with the requirements of the UK Takeover Code, Allergan announced that it does not intend to make an offer for Shire. Allergan...


Apr 19, 2018, 10:57 ET Allergan Issues Statement Regarding Press Speculation on its Strategic Review

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD...


Apr 13, 2018, 08:01 ET Allergan Announces Launch of the TrueTear® Intranasal Neurostimulation Device During 2018 ASCRS-ASOA Annual Meeting

Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, today announced the official launch of TrueTear®, the first and only...


Apr 03, 2018, 08:00 ET Allergan and Richter Announce Positive Topline Results from Third of Three Pivotal Trials of Cariprazine in Bipolar I Depression

Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Gedeon Richter Plc., today announced positive topline results for RGH-MD-53,...


Apr 02, 2018, 16:15 ET Allergan Receives 2018 ENERGY STAR® Partner of the Year - Sustained Excellence Award

Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced it has received the 2018 ENERGY STAR® Partner of the Year...


Apr 02, 2018, 08:00 ET Allergan to Report First Quarter 2018 Earnings and Host Conference Call and Webcast

Allergan plc (NYSE: AGN) today announced it intends to release first quarter 2018 financial results on Monday, April 30, 2018, prior to the open of...